Cell- and gene-therapy approaches to inner ear repair by Conde de Felipe, Magnolia et al.
Summary. Sensorineural hearing loss is the most
common sensory disorder in humans. It is primarily due
to the degeneration of highly specialised mechano-
sensory cells in the cochlea, the so-called hair cells.
Hearing problems can also be caused or further
aggravated by the death of auditory sensory neurons that
convey the information from the hair cells to the brain
stem. Despite the discovery of stem/progenitor cells in
the mammalian cochlea, no regeneration of either
damaged hair cells or auditory neurons has been
observed in mammals, in contrast to what is seen in
avians and non-mammalian vertebrates. The reasons for
this divergence have not yet been elucidated, although
loss of stem cells and/or loss of their phenotypic
plasticity in adult mammals have been put forward as
possible explanations. Given the high incidence of this
disorder and its economic and social implications, a
considerable number of research lines have been set up
aimed towards the regeneration of cochlear sensory cell
types. This review summarizes the various routes that
have been explored, ranging from the genetic
modification of endogenous cells remaining in the inner
ear in order to promote their transdifferentiation, to the
implantation of exogenous stem or progenitor cells and
their subsequent differentiation within the host tissue.
Prophylactic treatments to fight against progressive
sensory cell degeneration in the inner ear are also
discussed. 
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Introduction
Worldwide, 500 million people are estimated to be
affected by some form of hearing loss, and the World
Health Organization has estimated that this number will
rise to 900 million by 2050. This makes hearing
impairment the most common sensory disorder in
humans, with serious social and economic implications. 
In the majority of the cases, the cause for hearing loss is
directly or indirectly linked to degeneration and death of
specialized mechanosensory hair cells (HCs). These
cells translate the incoming sound waves into electrical
signals that are then carried to the brain via their
associated auditory neurons (spiral ganglion neurons,
SGNs), bipolar neurons that extend one process
peripherally (to the HC in the sensory epithelium) and
one process centrally (to auditory centres in the brain).
HC loss may result from excessive exposure to loud
stimuli, bacterial and viral infections, ototoxic drugs, and
mechanical trauma, with aging being an additional risk
factor. Furthermore, over a hundred genetic loci have by
now been identified that either cause deafness or convey
susceptibility to some environmental factors that affect
hearing (Hilgert et al., 2009; Dror and Avraham, 2010).
Work carried out using animal models has shown that
SGN degeneration may occur as a primary event, but it
most often follows HC death, probably due to the lack of
electric stimulation and/or some trophic factor normally
provided to them by the HCs. 
In the mammalian cochlea, HCs and SGNs are only
produced during the fetal stages and the capacity to
replace any of these sensory cells following damage is
lost soon after birth. This is in contrast to what is seen in
avians and non-mammalian vertebrates that are capable
of regenerating HCs throughout life (Brignull et al.,
2009). Studies in birds have shown that non-sensory
supporting cells (SCs) adjacent to damaged HCs may
transdifferentiate into new HCs. This regeneration
process can occur either directly, in the absence of
mitosis, or after re-entering the cell cycle (Roberson et
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al., 2004; Stone and Cotanche, 2007; Brignull et al.,
2009). Very importantly, afferent neurons establish
functional synaptic contacts with the new HCs, resulting
in significant functional recovery (Bermingham-
McDonogh and Rubel, 2003). On the other hand,
although Kelley et al. (1995) demonstrated a limited
capacity for regeneration of HCs in embryonic mouse
cochleae, cochlear SCs in the adult appear unable to
reconstitute degenerated HCs (Yamasoba and Kondo,
2006). Instead, their apical borders expand to fill the
lesion site and form a “scar”, with no transdifferentiation
into a HC phenotype taking place.
The reasons for the lack of regenerative capacity of
the adult mammalian cochlea are unkown. A few
possible explanations have been put forward. Warchol
(2011) has proposed that it may be the result of a trade-
off between phenotypic plasticity of the SC and sensitive
high-frequency hearing, with a concomitant reduction in
the number of HCs and further specialization of cochlear
SCs into morphologically different subtypes. The
complex cytoarchitecture observed in the mammalian
cochlea may have resulted in the development of
mechanisms that restrict the ability of SCs to divide and
transdifferentiate following HC loss. In general it is
considered that the regenerative ability of the sensory
organ (so-called Organ of Corti in mammals, OC) is
closely linked to the proliferative capacity of its SCs.
SCs in the mature OC in mammals are post-mitotic cells
and it has been hypothesized that their proliferative
ability is perhaps lost due to the absence of certain
mitogen receptors in these cells or the expression of
cyclin-dependent kinase inhibitors such as p27, and/or
changes in the actin cytoskeleton (White et al., 2006;
Burns et al., 2008; Warchol, 2011). It has also been
argued that pluripotent stem cells present in regenerating
organs such as skin are absent in the mature cochlea.
While stem-like cells have been isolated from the
vestibular organs of mature mice (Li et al., 2003a) and
even from the cochlea of neonatal mice (Oshima et al.,
2009), tissues where a limited amount of regeneration
occurs, this type of cell has not been identified in the
cochleae of adult mice (Oshima et al., 2007).
Hearing loss: Therapeutical approaches
At present, the only available treatments for patients
suffering from severe hearing loss are based on sound
amplification (hearing aids) and/or cochlear implants
(CIs). Cochlear implants are electronic devices that
bypass the degenerated HCs and directly stimulate the
remaining auditory neurons. Although SGNs have been
reported to survive for many years in the absence of
most or all the HCs, progressive degeneration of these
neurons takes place and evidence from animal studies
indicates that this degeneration may compromise the
efficacy of CIs (Shepherd et al., 2004). Therefore, the
success of CIs relies on the preservation of healthy
sensory neurons that transmit the signal to the brain. 
Although still far from the clinic, different avenues
are being explored in order to tackle the problem of
hearing loss, the two main objectives being the
regeneration of missing cell types and the maintenance
of remaining cochlear cells. Studies pursuing either of
these aims have been carried out using cell or gene
therapy, and/or the application of trophic factors. Critical
factors to be considered when contemplating possible
therapeutic approaches are the type of cell(s) damaged,
the cause and extent of damage, and the overall state of
the host tissue, influenced by parameters such as the
time passed since the otic injury. 
Regeneration of missing cell types
There are two possible routes aimed to regenerate
damaged HCs or SGNs. One consists in differentiating
other cell types into the sought-for phenotype or an
earlier progenitor and subsequently transplanting these
cells into the inner ear. Alternatively, already existing
endogenous cells may be stimulated to become
replacement cells. A number of excellent reviews have
been recently published on this subject (Brigande and
Heller, 2009; Groves, 2010; Jonkamonwiwat et al.,
2010; Shibata and Raphael, 2010).
Cell therapy approaches: Implantation of exogenous
cells
Considerations on the host cell type to be replaced
and the status of the host tissue
When evaluating the use of exogenous cells to
replace damaged HCs a number of important problems
emerge, such as: (a) the difficulty to access the auditory
epithelium in humans, which would imply invasive
methods for the administration of exogenous cells, (b)
the exposure of the implanted cells to a hostile
environment in the form of the endolymph, an
extracellular fluid with high potassium content that is
necessary for the correct functioning of the cochlea, and,
primarily, (c) the challenge of trying to insert exogenous
cells into such a highly organized structure as the OC.
Studies have shown the critical importance of
maintaining the correct numbers as well as the
organization of both HCs and SCs for the proper
functioning of the OC. Furthermore, the cells in this
epithelium are linked by tight junctions that prevent
mixing between the endolymph and the perilymph (Kim
and Raphael, 2007), but also complicate the insertion
and functional integration of exogenous cells into the
epithelium. In contrast, replacing damaged SGNs
requires considerably less surgical invasion and precise
integration of the transplanted cells in situ. It has already
been shown that transplants of exogenous embryonic
stem cells (ESCs) or ESC-derived neural progenitors
into the modiolus results in survival and migration of
these cells, and their differentiation into neurons that
extend processes towards appropriate targets in the
periphery (i.e. HC) and centrally, to the brain (Okano et
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al., 2005; Corrales et al., 2006; Sekiya et al., 2006; Shi et
al., 2007). Importantly, differentiation of implanted
ESCs into excitatory glutamatergic neurons has already
been shown in vivo (Reyes et al., 2008). While
acquisition of this phenotype is the sine qua non of
auditory nerve replacement, it is possible that other
features of auditory neurons (e.g. specific ion channels)
do not need to be faithfully replicated in order to
transmit some information from the HCs via the SGN to
the cochlear nucleus. Overall, these results hold promise
for an improved treatment of patients who either suffer
from primary neuronal degeneration or use CIs. Since
degeneration of SGNs following HC damage occurs
over several years after HC loss (Groves, 2010), a
reasonably large time window for therapy is offered.
The state of the host tissue is a critical factor to be
considered when contemplating any therapeutical
approach. Of note, increased survival and differentiation
of transplanted cells has been shown in damaged inner
ears, compared to uninjured controls (Ulfendahl et al.,
2007; Matsuoka et al., 2007). For example, Hu et al.
(2005c) reported higher survival rates of adult NSCs
implanted into the scala tympani (ST) of neomycin-
treated guinea pigs, compared to those implanted in
normal-hearing animals. Okano and colleagues (2005)
saw that approximately twice the number of transplanted
cells survived in injured ears compared to normal ears.
These data point to the release of some factor(s) from the
injured inner ear that enhances both survival and
differentiation of the exogenous cells. Regarding the
replacement of missing SGNs, damage clearly leads to
increased survival and migration of implanted cells. This
is thought to result not only from an augmented
production of trophic and chemotactic factors produced
by the host tissue, but also from an increase in the space
available for the implant, left behind by the degenerated
SGN bodies and auditory nerves (Sekiya et al., 2006;
Ogita et al., 2010). 
Various groups have also demonstrated that the
timing of the transplant following injury plays a critical
role in the survival and engraftment of the donor cells.
Overall, studies have shown that the number of
engrafted cells decreases as the latency between damage
and exogenous cell injection increases (Parker et al.,
2007). Lang and co-workers (2008) confirmed that there
is an optimal time window for engraftment and survival
of ESCs during the early post-injury period (within 1-3
days after injury). This effect of timing of transplantation
of the exogenous cells following injury to the inner ear is
thought to be due to increased metabolism in the early
post-injury cochlear micro-environment, with the
concomitant production and release of factors that are
otherwise not present in the healthy cochlea. In
agreement with this hypothesis is the observation by Tan
and colleagues (2008) that infiltration of labelled bone
marrow (BM)-derived cells into the damaged cochlea
during the first week after deafening coincides with a
transient increase in the expression of stromal-derived
factor 1 (SDF-1).
Considerations on the cell types to be used as donor
cells
Regarding the cell type to be used for implants, a set
of different variables must again be considered. Cells are
required that can survive and migrate to appropriate
locations once they are implanted. Survival of implanted
cells has in general been reported to be very low (Hu et
al., 2004, 2005c; Ulfendahl et al., 2007). Some
variability has been observed among different cell types,
and cell differentiation status prior to implantation
appears to also play a part. It is widely accepted that
differentiated donor cell types are more likely to elicit an
adverse immune response than undifferentiated ESCs,
since these latter do not express human leukocyte
antigen (HLA) proteins. On the other hand, different cell
types have been used as donor cells in transplantation
studies in the cochlea and no adverse immune reactions
have been reported, leading to claims that this organ is
an immunoprivileged site that will allow
xenotransplantation (Hildebrand et al., 2005; Regala et
al., 2005; Ulfendahl et al., 2007; Reyes et al., 2008). 
The implanted cells must also be capable of
differentiating into the desired phenotype(s) as well as
integrating and establishing adequate functional
connections within the tissue. This will likely depend on
both the local environment and the ability of the
implanted cells to receive and respond to the signals sent
by the host tissue. Various degrees of integration of the
implanted cells into the host tissue and subsequent
differentiation of these cells have been reported
(Corrales et al., 2006; Altschuler et al., 2008). Some
groups have observed the localization of donor cells to
target areas but in the absence of any sign of
differentiation or integration (Hildebrand et al., 2005).
However a few studies have demonstrated the
establishment of new functional connections between the
donor cells and the host tissue. Martínez-Monedero et al.
(2006) confirmed the ability of denervated HCs,
explanted from post-natal cochleae, to attract new
processes from neurons growing in their proximity, as
well as the formation of synapsin-expressing terminal
swellings at the contact points between neurons and
HCs. Formation of neurite projections from
differentiating donor cells implanted into the cochlear
nerve trunk toward the denervated OC was also shown
in vivo (Corrales et al., 2006). However, formation of
functional synapses has not been demonstrated yet, and
electrophysiological data are generally lacking.
Besides these considerations, a human source of
exogenous cells is required that allows the systematic
production of clinical-grade cells for transplants under
well-controlled conditions, amenable to standardization
and scaling-up (Rivolta, 2010). To date, the majority of
studies have been carried out using stem-like cells of
various origins. Nevertheless, these are still relatively
heterogeneous cell populations and in some cases their
availability implies going back to primary tissues as their
source. Consequently, efforts are currently being made
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by some groups to render the use of conditionally
immortal cell lines a safe option for possible therapies
(Pollock et al., 2006; Sekiya et al., 2007; Stevanato et
al., 2009). Safe and effective transplants of such cells
have been carried out in animals, with no reports of
tumour formation (Nicholl et al., 2005; Pollock et al.,
2006; Sekiya et al., 2007) In fact, some of these cell
lines have already been produced under good
manufacturing practice (GMP) conditions required for
clinical applications, and tested for the treatment of
disorders such as stroke (Pollock et al., 2006; Stevanato
et al., 2009). 
Route of implantation
Besides the cell type to be replaced and the source of
exogenous cells to be implanted, one must also consider
the route of implantation to be used (Jonkamonwiwat et
al., 2010). Minimal damage to the cochlear architecture,
together with implantation into locations that are as close
as possible to the target sites and that allow a widespread
distribution of the donor cells throughout the auditory
organ are desired features. Integrity of the membranes
that seal the endolymphatic and perilymphatic chambers
is critical for normal hearing and damage to these
membranes must therefore be avoided or minimized.
A considerable number of studies have been carried
out that delivered the donor cells into the fluid-filled
compartments of the cochlea, mostly into the easily
accessible ST. This latter approach results in widespread
distribution of the implanted cells while minimizing
mechanical trauma to the cochlear cytoarchitecture.
However, the flow of perilymph and concomitant
dispersal of donor cells into the cerebrospinal fluid has
been suggested as one of the likely reasons for the
decline in the number of surviving cells observed at the
injection site (Hildebrand et al., 2005; Coleman et al.,
2006). In addition, injections of donor cells in the ST has
yielded very low densities of exogenous cells in target
areas such as Rosenthal’s Canal (RC), where the spiral
ganglion cells are located, making this delivery route too
inefficient for SGN replacement therapy (Coleman et al.,
2006; Matsuoka et al., 2006; Altschuler et al., 2008).
Consequently, direct injection of donor cells into the
auditory nerve has been very often adopted as an
alternative route, that requires minimal surgical trauma
and results in extensive migration of the exogenous
cells, not only along the entire nerve but also to the more
distal scala media, where the HCs reside (Sekiya et al.,
2006; Lang et al., 2008). 
The route of implantation and subsequent
distribution patterns of the injected cells are thought to
play a role in the survival of donor cells. Overall, it
appears that cells implanted intra-neurally survive better
than those transplanted peri-neurally (Sekiya et al.,
2006). As mentioned before, in a number of studies the
donor cells were transplanted into the ST, with very low
survival rates. An example of this is the work carried out
by Ulfendahl et al. (2007) using ESCs. The authors
hypothesized that although the ST is an easily accessible
location, it probably lacks essential factors required for
the survival of transplanted cells. Importantly, survival
of the ESCs was greatly enhanced when these cells were
implanted together with small pieces of E13-E14 dorsal
root ganglion (DRG) tissue (Hu et al., 2005a), pointing
to the lack of some factor(s) in the adult cochlea that
might be critical for the survival of the exogenous cells.
Additionally, different groups (Hildebrand et al., 2005;
Lang et al., 2008) have shown that the survival of
implanted cells is higher in the perilymph than in the
endolymph. 
Some studies have demonstrated that the location of
the implanted cells within the tissue also affects their
differentiation. Parker and colleagues (2007) observed
that NSCs transplanted into hearing-damaged mice
differentially regulated their gene and protein expression
depending on their location within the OC,
demonstrating an influence of the cochlear micro-
environment on NSC differentiation. Different
morphology of neuralized ESCs depending on their
location within the host tissue was also reported by
Sekiya and co-workers in the inner ears of deafened rats
(2006). Carrying out transplants of neuralized ESCs into
the cochleae of deafened gerbils, Lang et al. (2008)
showed that a small number of donor cells that were
localised within the RC had differentiated into cells that
expressed neurofilament-200, a marker of mature
neurons, while no signs of neuronal differentiation were
found outside this region. These are encouraging
observations in support of cell therapy approaches for
the treatment of hearing loss, as they indicate that the
mature mammalian cochlea, despite its inability to
regenerate lost cells, may retain the signals necessary to
drive differentiation of stem cells towards cochlear cell
phenotypes.
Cell types used for cell therapy in the inner ear
Having outlined some of the most important issues
to be addressed when considering a cell therapy
approach for treating hearing loss, we will now proceed
to summarize the main findings obtained with the
various types of cells tested. 
(a) Embryonic stem cells (ESCs). In a series of studies
undifferentiated ESCs have been directly injected into
the cochlea. One argument in favour of this approach is
the plasticity of these cells, which might translate into a
better response to the different micro-environmental
cues the implanted ESCs will encounter within the
various cochlear compartments; this would open the
door to a possible regeneration of several cellular
phenotypes, derived from the same transplant (Shi et al.,
2007). Another advantage of using undifferentiated
ESCs is their low immunogenicity, which makes a host
immune response less likely.
Mouse ESCs transplanted into injured vestibulo-
cochlear nerves of adult rats and guinea pigs survived up
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to at least 9 weeks (Hu et al., 2004; Regala et al., 2005)
and a fraction of these cells differentiated into either
glial or neuronal lineages. Importantly, implanted cells
were detected not only at the site of injection but also
within the brain stem. When ESCs were implanted into
the ST (Ulfendahl et al., 2007), surviving cells were
identified close to the spiral ganglion region and along
the nerve fibers projecting to OC, as well as in the scala
vestibuli, indicating migration towards functionally
relevant locations. Nevertheless, the survival rate of the
transplanted cells was very low (1.1%-1.5%). Cell
survival and neuronal differentiation of ESCs injected in
the cochlea was greatly enhanced when the stem cells
were implanted together with small pieces of embryonic
mouse DRG tissue (Hu et al., 2005a). Moreover,
formation of neurite-like projections from ßIII-tubulin-
expressing donor cells towards peripheral SGN
processes was only observed in the presence of the DRG
co-graft. However, no differentiation of the ESCs to
myosin VIIa-positive cells (a protein typically expressed
by HCs) took place.
Altschuler et al. (2008) took the studies on survival
and differentiation of ESCs implanted into the cochlea
one step further and reported that continuous intrascalar
administration of the neurotrophic factor (NF) glial-
derived neurotrophic factor (GDNF) following injection
of mouse ESCs into the cochleae of hearing-damaged
guinea pigs resulted in increased survival of the
implanted cells and a much higher rate of neuronal
differentiation, compared to implants that did not receive
GDNF. Moreover, the ESC-derived neurons were mostly
of an excitatory glutamatergic phenotype (indicated by
the expression of vesicular glutamate transporters,
VGLUT1/2), and thus appropriate for functional
replacement of auditory neurons. Most of the processes
extended by the ESC-derived neurons were directed
towards the OC or towards remaining SGNs in the
modiolus. Unfortunately, no functional studies were
conducted.
The data obtained from the aforementioned studies
clearly indicate that successful differentiation and long-
term integration of implanted ESCs will likely require
either the co-grafting of some other tissue, or the
simultaneous application of appropriate NFs.
Alternatively, ESCs can be pre-differentiated in vitro in
order to promote their final progression towards the
desired phenotypes following implantation. One of the
clear advantages of these latter methods, compared to
the implants of undifferentiated ESC, is the diminished
risk of tumour formation in vivo. The appearance of
teratomas is always a major concern when injecting
undifferentiated ESCs (Erdo et al., 2003; Sell, 2004),
although it has not been reported by any of the groups
cited above (Hu et al., 2005a; Regala et al., 2005;
Altschuler et al., 2008). Other advantages are the fact
that, unlike ESCs, ESC-derived populations may not be
totally dependent on the cochlear environment for their
survival and correct differentiation. Additionally, pre-
differentiation may allow the selection of a more
homogenous and appropriate population of cells for
implants. Since lineage analysis studies have provided
evidence that SGNs and HCs are derived from a
common neural precursor cell, a very frequently adopted
approach has been the differentiation of ESCs to
neuroectodermal progenitors prior to transplantation
(Hildebrand et al., 2005; Coleman et al., 2007; Lang et
al., 2008). These cells, albeit committed to the neural
lineage, can still integrate into inner ear tissue and
respond to various signals present within the cochlear
environment (Corrales et al., 2006). Survival of these
cells after implantation into either the ST (Coleman et
al., 2006) or the auditory nerve (Sekiya et al., 2006) has
already been demonstrated. Regarding their
differentiation, divergent results have been obtained
using various animal models (Hildebrand et al., 2005;
Sekiya et al., 2006). Hildebrand and co-workers (2005)
failed to detect any further differentiation of ESCs that
were partially pre-differentiated to the neuroectodermal
lineage following their implantation into deafened
guinea pigs, in spite of long survival times and
localization close to the damaged OC. In contrast,
Corrales and colleagues (2006) reported progressive
neuronal differentiation of ESC-derived mouse neural
progenitor cells after injection into the cochlear nerve of
immunosuppressed gerbils, with formation of abundant
neuronal processes that traversed RC and grew towards
the HCs in the OC. The observed projection pattern
appeared to indicate that the newly formed neurites
followed the former pathways of degenerated SGNs,
reponding to cues probably sent to them from the
denervated OC. Moreover, these neurons expressed
peripherin, a protein expressed in sensory neurons.
Unfortunately, the authors could not carry out any test to
assess functional recovery in the implanted animals, due
to the formation of thick scar tissue at the site of surgery.
Promising results were obtained by Okano and
colleagues (2005), who implanted mouse ESC-derived
neural progenitors into the cochlear modiolus of guinea
pigs. This group confirmed survival and neural
differentiation of the donor cells, which were shown to
extend neurite projections toward peripheral and central
auditory targets. Furthermore, auditory brain stem
response (ABR) measurements indicated the potential of
the transplanted cells for functional recovery of the
damaged cochleae, although no direct evidence was
presented for the establishment of synapses. Later on,
Matsumoto and co-workers (2008) demonstrated the
potential of ESC-derived neurons to form synaptic
contacts with auditory HCs.
An alternative to driving ESCs into the
neuroectodermal lineage prior to transplantation into the
inner ear is to specifically pre-differentiate ESCs in vitro
into the sought-after cellular type, i.e. auditory neurons
or HCs. Coleman et al. (2007) co-cultured ESC-derived
neural progenitors (grown in the form of floating
aggregates termed embryoid bodies) with HC explants
and observed that a proportion of the ESCs differentiated
into neurofilament-68-protein-positive bipolar neuron-
5
Approaches to inner ear repair
like cells, analogous to mammalian auditory neurons
grown in vitro. However although neuronal processes
were observed, the authors did not observe any
significant growth of these processes toward the HC
explants. An interesting study carried out by Shi and
colleagues (2007) demonstrated that, although human
ESCs (hESCs) could be induced to differentiate into
neurons, specification of sensory neurons required the
addition of BMP-4 to hESC-derived neural progenitor
cultures. The addition of BMP-4 to the cultures led to
significant sensory neuron differentiation, characterized
by the expression of peripherin, GATA3, neurogenin 1
(ngn1), Brn3a, TrkB and TrkC. The newly obtained
neurons were shown to make contacts with HCs in
denervated mouse OC explants and expressed synapsin,
suggesting synapse formation. The same observation
was made in vivo using a gerbil model: hESC-derived
neurons engrafted in the auditory nerve trunk expressed
peripherin, and 60 days after implantation had sent out
abundant neurites that grew both peripherally toward the
cochlea and centrally toward the brain stem.
Unfortunately, the authors could not demonstrate
synapse formation between the transplanted cells and the
endogenous HCs.
Regarding in vitro differentiation of ESCs into HCs,
work carried out by Heller and his group (Li et al.,
2003b; Oshima et al., 2010) established a series of
culture conditions that resulted in the expression of
markers typical of HCs (e.g. Math1, Brn3c, Myosin
VIIa) or SCs (Jagged-1, p27) in a proportion of ESC-
derived neural progenitors. Importantly, further
differentiation of these cells was accomplished by either
co-culturing them with stromal cells derived from the
chicken utriculus or in vivo, by engrafting them into
developing chick otic vesicles. Under these conditions,
the authors observed formation of hair-bundle-like
protrusions that stained for espin and displayed
electrophysiological responses similar to those obtained
from immature HCs. 
An interesting alternative to differentiating ESCs
towards either auditory neurons or HCs prior to their
implantation into a host tissue has been presented by
Reyes and colleagues (2008). Making use of the already
available knowledge on the cues necessary for SGN
differentiation in vivo, this group employed a mouse
ESC line that carries a tet-inducible ngn1 gene and
showed that transient expression of this gene promoted
the neuronal differentiation of cultured ESCs.
Subsequent treatment with brain derived neurotrophic
factor (BDNF) and GDNF resulted in 75% of these cells
exhibiting a glutamatergic phenotype after 5 days in
vitro. This inducible system allowed the authors to
implant undifferentiated ESCs into deafened guinea pig
cochleae and induce them to become neurons by forcing
them to transiently express ngn1.The approach resulted
in high rates of neuronal differentiation of the implanted
ESCs. Upon subsequent infusion of BDNF and GDNF a
high proportion (approx. 79%) of the ESC-derived
neurons acquired a glutamatergic phenotype. However,
no electrophysiological data were presented.
As an alternative to the differentiation of ESCs into
neurons, Olivius and colleagues transplantated
embryonic DRG neurons into the cochlea (Hu et al.,
2004; Regala et al., 2005; Ulfendahl et al., 2007). They
showed survival and migration of the implanted cells to
the spiral ganglion, along the nerve fibers projecting to
the OC and towards the brain stem. The rate of cell
survival was very low, although a clear improvement
was observed following the application of nerve growth
factor (NGF) (Hu et al., 2005b) or a combination of
BDNF and ciliary neurotrophic factor (CNTF).
Moreover, in the presence of NGF, the DRG cells
formed extensive neurite projections that in some cases
appeared to contact the host SGN, although no
functional interaction between the donor tissue and the
host neurons was demonstrated in this work. 
(b) Adult or tissue-derived (somatic) stem cells. Several
types of stem or progenitor populations are found in the
adult organism that may serve as an alternative to the use
of ESCs. The former cell types have been attributed a
more limited ability for multi-lineage differentiation
compared to ESCs. Nevertheless, they offer important
advantages such as the possibility of autologous
transplants, thereby avoiding problems of immune
rejection, and the fact that they can be isolated from the
adult organism without facing ethical conflicts raised by
the use of ESCs. Below we summarize the efforts made
towards achieving the regeneration of inner ear sensory
cell types using different sources of adult
stem/progenitor cells. 
(b1) Neural stem cells. Despite the ability of ESCs to
give rise to a plethora of cellular phenotypes, ESCs
implanted into the cochlea of experimental animals most
commonly differentiate into glial cells rather than into
neurons (Altschuler et al., 2008; Lang et al., 2008). A
number of groups have therefore employed neural stem
cells (NSCs) instead of ESCs in an attempt to facilitate
the differentiation of the transplanted cells into the
auditory sensory lineage. The ability of NSCs to give
rise to SGN-like neurons was demonstrated in vitro by
Wei et al. (2008), who also reported the formation of
functional synapses of these cells with HCs and
deafferented SGNs. In vivo, NSCs have been shown to
differentiate into neural, glial and HC-like phenotypes
(Tateya et al., 2003; Hu et al., 2005c; Parker et al.,
2007). Hu and colleagues (2005c) infused adult mouse
NSCs into the ST of guinea pig cochleae and reported
that survival and neuronal differentiation appeared to be
enhanced within injured inner ears, as compared to
normal controls (Hu et al., 2005c); nevertheless, overall
survival was very poor in both groups (Ito et al., 2001;
Hu et al., 2005c). The authors reported migration of the
injected cells along the auditory nerve tract to locations
near functionally important structures, such as the OC
and the spiral ganglion. However, no contact was
observed between the implanted cells and the host tissue
(Ulfendahl et al., 2007). Differently from the results
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obtained by Hu et al. (2005c), Parker and co-workers
(2007) implanted a mouse clonal NSC line into sound-
damaged mouse and guinea pig cochleae and reported
the differentiation of these cells into a wide range of
phenotypes, depending on their localization within the
cochlea. Two to six weeks after implantation, a
proportion of these cells was found in the spiral ganglion
area and appeared to be differentiating into satellite cells,
Schwann cells, and even SGNs. Very importantly, some
of these cells also labelled for synapsin, suggesting a
possible competence for synaptic transmission.
Altogether, these data point towards an influence of the
microenvironment of the cochlea on the differentiation
of the implanted cells.
In another set of experiments Hu and colleagues
(2005c) transduced NSCs with neurogenin2 (ngn2) to
further promote their differentiation towards a neuronal
phenotype. They observed better survival rates of ngn2-
expressing NSCs implanted into normal hearing guinea
pig cochleae, compared to control NSCs, although the
numbers of surviving cells were very low in both groups.
Neuronal differentiation was also enhanced by ngn-2
transduction upon which NSC-derived ‚III-tubulin-
expressing cells were identified in all inner ears that
contained surviving NSCs. On the other hand,
embryonic NSCs transduced with the Atoh1 gene gave
rise to both neurons and HCs, following their
implantation into normal guinea pig cochleae (Han et al.,
2010).
(b2) Bone marrow stem cells. Mesenchymal and
hematopoietic stem cells. Initially isolated from BM and
later on from other tissues such as muscle, synovial
membranes, peripheral blood, umbilical cord blood and
adipose tissue, mesenchymal stem cells (MSCs) are a
heterogeneous population of stem/progenitor cells with
pluripotent capacity to differentiate into cell types of all
three embryonic layers (Krabbe et al., 2005). They are
more easily harvested and expanded ex vivo than NSCs.
Importantly, they have been extensively used in clinical
applications, so their safety is known.
There have been a considerable number of reports on
the neural differentiation of MSCs (Sánchez-Ramos et
al., 2000; Woodbury et al., 2000; Deng et al., 2001).
Interpretation of these data must nonetheless be carried
out with caution, as it has been shown in some instances
that rapid phenotypic changes of treated MSCs towards a
neuronal morphology, are often the result of a cytotoxic
effect (Jin et al., 2003; Lu et al., 2004). Furthermore,
expression of neuronal or glial proteins (e.g. ßIII-tubulin,
MAP-2, GFAP) has been demonstrated in standard MSC
cultures, in the absence of any specific induction
protocol (Tondreau et al., 2004). In addition, cell fusion
phenomena have been observed between transplanted
MSCs and host tissue. Consequently, confirmation that a
transdifferentiation process of MSCs towards neural
lineages has taken place requires not only that the
possibility of cell fusion has been excluded, but also that
morphological, immunocytochemical and electro-
physiological studies are carried out (Jin et al., 2003;
Krabbe et al., 2005). 
The use of MSCs as donor cells for transplantations
is further complicated by the fact that it is not yet clear
which cell population is responsible for the observed
cases of MSC transdifferentiation (Song and Sánchez-
Ramos, 2003). There is some evidence for the presence
of a set of quiescent primordial stem cells in adult tissues
such as the BM and the brain that can differentiate into
mesodermal, neuroectodermal and endodermal cell
types, and thus might lead to an assumption of
transdifferentiation of the cell cultures they are
contaminating (Jiang et al., 2002b; Krabbe et al., 2005). 
These stem cells have been termed multipotent adult
progenitor cells (MAPCs) (Jiang et al., 2002a). In a
recent publication, Kuroda and colleagues (2010) have
also reported the isolation of a type of human MSC that
can give rise to cells corresponding to the three germ
layers. These cells are present at very low frequencies in
primary cultures of BM aspirates and have been named
multilineage differentiating stress enduring (Muse) cells,
as their numbers increase during passaging of BM
cultures and exposure to stress conditions. An alternative
hypothesis that has been proposed is that adult tissues
might contain mixed populations of progenitor cells
derived from distinct embryonic germ layers.
Regarding the transplants of BM-derived stem cells
into the cochlea, survival and migration of these cells
have been demonstrated (Naito et al., 2004; Matsuoka et
al., 2007) and there are some reports on the
differentiation of injected MSCs into neuronal-like cells
in vivo (Naito et al., 2004). In order to investigate the
potential for transdifferentation of BM-derived cells in
the cochlea, Tan et al. (2008) isolated these cells from
GFP-transgenic donor mice and engrafted them into
lethally irradiated mice. Shortly after acoustic trauma,
prominent GFP-positive cell infiltration was observed in
the cochlea, outside the sensory epithelial regions. This
infiltration was most intense during the first week after
deafening, coinciding with an up-regulation of SDF-1.
However, most of the infiltrated BM-derived cells were
identified as macrophages and GFP-positive cells did not
exhibit any cochlear characteristics. No sign of ABR
threshold recovery was observed up to 8 weeks after
deafening. The main conclusion from this work was that,
although acoustic damage resulted in a clear increase of
the homing ability of the BM-derived cells to the
cochlea, compared to control cochleae, these cells did
not transdifferentiate into any cochlear cell type and did
not contribute to its repair. As possible explanations for
these results, the authors suggested that the damaged
cochlea might not be sending out the necessary cues
needed to attract pluripotent cells from the BM-derived
cell pool and/or it might not provide the regenerative
signals required for BM-derived cells to trans-
differentiate into appropriate cell types. Similar results
were obtained by Lang and co-workers (2006), who
confirmed homing of BM-derived cells to the inner ear
of irradiated mice, outside the epithelial regions;
although some implanted cells expressed proteins typical
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of specialized fibrocytes involved in ion transport, the
authors did not observe transdifferentiation of any donor
cell into either HCs or neurons.
Overall, MSCs have been shown to survive in and
migrate to multiple sites within the cochlea following
implantation (Matsuoka et al., 2007). However, the rates
of neuronal differentiation of these cells are reportedly
very low, both in normal and in hearing-damaged animal
models. In light of these results, Ogita et al. (2010)
adopted a method for the neural induction of BM-MSCs
isolated from adult guinea pigs prior to their transfer into
the modiolus of adult guinea pigs. Neuronal
differentiation of the MSCs was observed in 18,6 ± 6,4%
and 24.1±5.3% of the transplants in the normal and
damaged cochleae, respectively. However, no difference
was found between transplanted and control animals in
the number of surviving SGNs following ouabain
treatment, indicating that the transplanted cells did not
promote the survival of host SGNs. This was consistent
with the ABR results, showing that no significant
functional recovery of the damaged cochleae had
occurred. This result differed from the recovery of ABR
thresholds observed by the same group when using
mouse ESC-derived neural progenitors (Okano et al.,
2005). It is possible that the MSCs did not differentiate
into the appropriate neuronal subtype (glutamatergic),
and thus lacked the characteristics of auditory neurons.
The ability of MSCs to differentiate into glutamatergic
neurons was demonstrated in vitro by Kondo and
colleagues (2005). These authors observed that, although
a marked up-regulation of neuronal markers was
observed in mouse BM-MSCs exposed to bFGF/
Forskolin, expression of sensory neuronal markers was
only detected when the cells were also treated with a
combination of Shh and RA, two molecules that are
secreted in the vicinity of peripheral sensory ganglia
during embryogenesis. Co-culture experiments with pre-
natal mouse OC explants revealed that the BM-MSC-
derived neurons extended processes towards HCs. 
Not only have BM-MSCs been shown to
differentiate into glutamatergic neurons in vitro, but also
into HC-like cells, as reported by Jeon and colleagues
(2007). This group used a combination of growth factors
to drive mouse BM-MSCs into a neurosensory
progenitor phenotype. As observed by Heller’s group (Li
et al., 2003b) with ESCs, further differentiation of the
progenitors into a mature HC phenotype (e.g. expression
of markers such as myosin VIIa, espin, and presence of
protrusions resembling stereociliary bundles) was
observed when these cells were either co-cultured with
embryonic day 3 (E3) chick otocyst cells or injected ex
vivo into E3 chick otocysts. Alternatively, further
maturation of the progenitors was achieved by forced
expression of the transcription factor Atoh1, required for
HC formation in the inner ear. 
(b3) Olfactory bulb precursor cells. The olfactory
neuroepithelium is the only tissue in the body where
damaged or dead neurons are replaced throughout life,
and this is due to the presence of multipotent stem cells
(Roisen et al., 2001; Othman et al., 2005). These cells
can be easily and abundantly obtained, making this
tissue a very important source of stem cells for
autologous transplantation. Following culture of mouse
olfactory precursor cells in the presence of conditioned
medium from adult mouse cochlear cultures or in co-
culture with these cells, Doyle and colleagues (2007)
reported differentiation of a proportion of these
precursors into cells that expressed proteins found in
HCs (i.e. myosin VIIa, espin, calretinin, prestin). These
results pointed to the presence of soluble factors in the
cochlear cultures capable of inducing differentiation of
non-auditory cells. 
(b4) Ependymal cells. A population of proliferative cells
that exhibit morphological and functional characteristics
similar to those of HCs was isolated by Wei and co-
workers (2008) from the ependymal layer of the lateral
brain ventricle of adult rodents and humans. These cells
expressed various HC proteins (e.g. myosin VIIa,
myosin VI, the HC synaptic protein ribeye) and large-
conductance FM1-43 permeable channels, possessed
stereociliary and kinociliary bundles, and were capable
of establishing functional synapses with primary SGNs
in vitro. Interestingly, these cells incorporated well into
the sensory epithelia of explanted cochleae from which
HCs had been eliminated. The authors thus proposed
ependymal cells as candidates to take over functional
roles of HCs in the damaged inner ear.
(b5) Inner ear stem cells. Stem cells of the inner ear
have been isolated from the vestibular organs of mice (Li
et al., 2003a; Oshima et al., 2007), from the mouse OC
(Oshima et al., 2007; Savary et al., 2007, 2008) and from
the spiral ganglion (Rask-Andersen et al., 2005; Oshima
et al., 2007), applying a sphere-formation assay routinely
used with CNS stem cells (Martínez-Monedero et al.,
2007). Li and colleagues (2003a) showed that inner ear
stem cells isolated from the adult mouse utricle could
give rise to cells from the three germ layers. Moreover
they could also differentiate into auditory neurons and
HC-like cells that expressed multiple HC markers,
presented hair-bundle-like protrusions, and expressed
functional ion channels similar to those of embryonic
HCs. Martínez-Monedero and co-workers (2008)
demonstrated that this differentiation could occur
spontaneously in vitro, in the absence of any added
growth factor. Inner ear stem cells gave rise to HC-like
and glial cells, as well as to auditory-like neurons that
responded to glutamate, fired action potentials and sent
out processes towards explants of denervated OCs,
where they formed contacts with HCs. Very relevant is
also the finding by Rask-Andersen and colleagues
(2005) who described a stem/progenitor cell population
present in adult human and guinea pig spiral ganglia.
These cells formed nestin-expressing spheres in vitro
and could differentiate into neurons and glial cells. The
newly emerged neurons expressed TrkB and TrkC,
receptors for the NFs BDNF and neurotrophin-3 (NT-3).
These data support the notion that inner ear stem cells
keep some kind of memory of their tissue of origin, and
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seem to follow an innate program to differentiate
towards the corresponding auditory phenotypes. Oshima
and co-workers (2007) pointed out intrinsic differences
in the potential of stem cells isolated from distinct inner
ear tissues to give rise to auditory phenotypes.
Accordingly, spiral ganglion-derived spheres appear to
give rise mostly to neurons and glial cell types, while
spheres derived from the OC or vestibular sensory
epithelia most frequently give rise to HCs. 
An interesting population of auditory progenitors
was identified by Rivolta and his group (Chen et al.,
2007, 2009) in cochleae from 9-11-week-old human
fetuses (human fetal auditory stem cells or hFASCs). In
contrast to some of the progenitors described above
(Rask-Andersen et al., 2005; Savary et al., 2007), these
cells were capable of undergoing long-term in vitro
expansion (i.e. for at least up to 1 year). Furthermore,
hFASCs could differentiate into HC-like and sensory
neuron-like cells that exhibited functional and
electrophysiological properties similar to those of
developing cochlear HCs and auditory neurons in vivo;
cells expressing SC markers were also obtained from
hFASCs. 
The presence of stem cells in the post-natal inner ear
appears contradictory with the observed lack of
regeneration in the mature cochlea following otic
damage. However, lower numbers of sphere-forming
cells in early postnatal cochleae compared to embryonic
tissue have been reported by Savary and co-workers
(2008), and Oshima and colleagues (2007) recently
demonstrated that there is a radical loss of stem cells in
the mammalian cochlea during postnatal maturation of
the auditory system. While cochlear tissues isolated from
mice not older than 3 weeks of age harbour sphere-
forming cells, this capacity appears to be practically
absent in the cochlea of older mice. This seems to be due
to either death of these stem/progenitor types or to a loss
of their stem cell features. Regarding this latter
possibility, in the young mammalian cochlea it is not yet
clear from which cell population stem cells are derived
from. Zhai and co-workers (2005) isolated a population
of HC progenitors from the lesser epithelial ridge (LER)
of neonatal rats. This tissue is juxtaposed to the outer
hair cells and, together with the medially located greater
epithelial ridge (GER), has been proposed as a potential
source for HC progenitors, as both of these tissues may
give rise to HCs when forced to express Atoh1 (Zheng
and Gao, 2000; Shou et al., 2003; Zhai et al., 2005). Zhai
and colleagues (2005) demonstrated that isolated LER
cells grown as spheres in the presence of EGF
proliferated and could differentiate into HC-like and SC-
like cells when co-cultured with utricular mesenchymal
cells, in a pattern reminiscent of the sensory epithelium
in vivo. In another set of experiments, Malgrange and
colleagues (2002) detected nestin expression in the GER
region and below the IHC of rats between embryonic
day 19 (E19) and postnatal day 7 (P7); they observed
that in vitro non-adherent culture of nestin-positive cells
isolated from the newborn rat OC led to their
differentiation into HC-like and SC-like cells.
Interestingly, nearly one third of the HC-like cells
present after 2 days of suspension culture were produced
following cell division, as indicated by myosin
VIIa/BrdU double labeling. 
It has also been hypothesized that HC progenitor
cells in the early postnatal period might in fact be SCs,
as it has been shown that SCs isolated from neonatal
mice can divide and transdifferentiate into HC-like cells
in vitro (White et al., 2006). Interestingly, an Abcg2-
expressing side population (SP) of progenitor cells has
been identified within the population of SCs in the P3
mouse cochlea and can be isolated by FACS sorting
(Savary et al., 2007). These cells also express another
stem cell marker, Musashi1, proliferate and give rise to
HCs and SCs in vitro. Of note, they have a very limited
capacity for self-renewal (i.e. only two passages), in
contrast to stem cells isolated from the vestibular
system, where a limited amount of HC regeneration has
been observed. Intrinsic changes in the ability of SCs to
give rise to HCs over time have also been reported.
White and co-workers (2006) demonstrated that SCs
isolated from P14 mouse cochleae failed to down-
regulate the cyclin-dependent kinase inhibitor p27,
compared to cultures of SCs isolated from neonatal
mice. This inability to re-enter the cell cycle was
associated with lower numbers of cells trans-
differentiating into HCs. In addition to a loss of
phenotypic plasticity of progenitor cells during
maturation of the mammalian cochlea, the observed lack
of regeneration of lost cell types in the injured auditory
system might also be related with the presence of in vivo
mechanisms that are inhibitory for cell proliferation.
Data from different groups (White et al., 2006; Savary et
al., 2007) point to the existence of pools of progenitor
cells present in the OC of post-natal animals that are
capable of proliferating under the appropriate in vitro
culture conditions following their isolation from the
original tissue.
Regeneration by endogenous cell types
As already mentioned above, one of the main
hurdles when approaching inner ear cell therapy is the
correct integration of the transplanted cells into the host
tissue. Transdifferentiation of endogenous inner ear cell
types might overcome this problem (Shibata and
Raphael, 2010). Studies on avians and other non-
mammalian systems (Stone and Cotanche, 2007;
Cotanche, 2008; Yu et al., 2010), and the similarities
found with embryonic and neonatal mammalian auditory
organs (Fekete and Wu, 2002; Daudet and Lewis, 2005)
have led to the hypothesis that de-differentiation of SCs,
non-sensory cells that are adjacent to HCs and that share
a common precursor with them, might be a potential
route to the replacement of HCs. While continued
expression of the cell cycle inhibitor p27 in HCs and
SCs of the mature avian sensory organ does not appear
to inhibit regeneration (Cotanche and Kaiser, 2010),
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failure of the adult mammalian SCs to re-enter the cell
cycle has been attributed, among other reasons, to their
inability to suppress this inhibitor (White et al., 2006;
Ono et al., 2009). Therefore, some of the attempts to
obtain new HCs have focused on the down-regulation of
this and other inhibitors such as retinoblastoma (Rb),
which is also plays a role in maintaining the postmitotic
state of SCs and HCs (Sage et al., 2005; Laine et al.,
2007). Indeed, inactivation of these proliferation
inhibitors in mammalian SCs has led to cell cycle re-
entry of some SC populations (Minoda et al., 2007; Ono
et al., 2009; Yu et al., 2010). Moreover, while some
groups have not observed transdifferentiation of the
cycling SCs into HCs, others have reported the
production of excess SCs as well as supernumerary HCs
(Chen et al., 2003; Sage et al., 2005, 2006; Weber et al.,
2008) following mitosis. However, this abnormal
proliferation of SCs ultimately resulted in markedly
increased apoptotic rates of the newly generated cells
which in turn led to a disruption of the sensory
epithelium and subsequent hearing loss (Sage et al.,
2005; Laine et al., 2007; Weber et al., 2008; Ono et al.,
2009; Groves, 2010). Similarly, inactivation of Rb in
postmitotic HCs was shown to result in cell cycle re-
entry, although these cells died at different stages before
mitosis was complete (Weber et al., 2008).
Failure of SCs that have re-entered the cell cycle to
give rise to HCs has led to the hypothesis that additional
factors are required. A main candidate is Math1/Atoh1,
encoding a basic helix-loop-helix transcription factor
and considered to be a master gene for the specification
of the HC lineage (Woods et al., 2004; Jeon et al., 2007;
Han et al., 2010). Absence of Atoh1 in knock-out mice
results in the loss of HCs in the sensory epithelium and
disrupted differentiation of cochlear SCs (Bermingham
et al., 1999; Woods et al., 2004). On the other hand, it
has been reported that over-expression of this gene may
lead to the formation of supernumerary HC-like cells
(Zheng and Gao, 2000; Zheng et al., 2000; Gubbels et
al., 2008) both in vitro and in vivo, and this may occur in
the absence of proliferation (Shou et al., 2003). These
cells have been shown to express HC proteins such as
myosin VIIa and calretinin and display HC morphology
and stereociliary bundles (Zheng et al., 2000; Kawamoto
et al., 2003; Shou et al., 2003; Izumikawa et al., 2005).
In some cases, the newly emerged HCs exhibited
electrophysiological properties similar to those of
already existing HCs and some appeared to attract
neurofilament-bearing processes from either the OC or
the cochlear nucleus (Kawamoto et al., 2003; Gubbels et
al., 2008). Furthermore, Izumikawa and co-workers
(2005) reported reduced ABR thresholds in the ears of
hearing-damaged adult guinea pigs that had been
transduced with an Atoh1-GFP construct, compared to
non-inoculated control ears. This was associated with the
appearance of a substantial number of mature HC-like
cells in the deafened cochlea. The same group observed
that, while novel HCs detected within the OC exhibited
normal HC-like morphology and orientation, these
features were not maintained in neighbouring ectopic
HCs. In fact, some of these cells displayed a mixed
phenotype between HCs and SCs, pointing to
transdifferentiation of SCs to HCs following
misexpression of Atoh1 (Izumikawa et al., 2005). As
mentioned above, other non-sensory inner ear cell types
have been shown to give rise to new HCs following
Atoh1 over-expression; this is the case for cells present
in the GER and LER (Zheng et al., 2000; Shou et al.,
2003).
With regards to transdifferentiation of non-sensory
cells to HCs via their genetic manipulation it is very
important to bear in mind the status of the damaged
tissue before its repair (Izumikawa et al., 2005). SCs in
damaged cochleae undergo a series of marked
morphological changes, expanding and forming scars
that prevent the perilymph and endolymph from mixing
(Oesterle and Campbell, 2009). Extensive otic injury can
ultimately result in the absence of differentiated SCs,
which are replaced by a simple epithelium with cuboidal
or flat appearance; forced expression of Atoh1 in this
epithelium does not lead to any morphological changes
and HCs are not regenerated, indicating that the presence
of differentiated SCs is a prerequisite for Atoh1-
mediated transdifferentiation (Izumikawa et al., 2008).
Together with Atoh1, the Notch signalling pathway
also plays a key role in regulating the numbers of HCs
that form in the OC. It has been shown that inhibition of
this pathway in the mammalian inner ear leads to the
formation of supernumerary HCs derived from either the
transdifferentiation of SCs into HCs and/or the
differentiation of sensory progenitor cells still present in
early postnatal cochlear tissue (Zine et al., 2000; Kiernan
et al., 2005; Yamamoto et al., 2006; Doetzlhofer et al.,
2009; Groves, 2010). Nevertheless, this effect gradually
diminishes during development in mammals (Zine et al.,
2000) and is practically absent in adults. This is thought
to result from changes in the expression of Notch
pathway components (Hori et al., 2007; Batts et al.,
2009; Groves, 2010). Work carried out by Ito’s group
(Hori et al., 2007) has revealed very low or absent
Notch1 and Jagged1 expression in the cochlea of adult
guinea pigs, in contrast with the higher expression levels
found in the GER and SCs of embryonic auditory
epithelia. In addition, and in agreement with the results
obtained by Batts and co-workers (2009), Hori and
colleagues (2007) observed up-regulation of both genes
in the inner sulcus region of the auditory epithelium
following ototoxic treatment of adult animals. Notch
inhibition in these animals led to the formation of
ectopic HCs, in contrast to its effects on the cochleae of
normal-hearing control animals. Damage prior to Notch
inhibition was therefore required for ectopic HC
formation to take place. Importantly, a time window was
identified in mammals when interference with Notch
pathway activation may lead to an increase in HC
production in damaged auditory epithelia. This appears
to be dependent on the species as well as on the severity
of the lesion (Oesterle et al., 2008; Batts et al., 2009).
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Promoting the survival of cell types that remain in
the cochlea following otic injury
Cell therapy approaches: Introduction of exogenous cells
A very important aspect of inner ear therapy consists
in promoting the survival of cell types that remain
following otic injury. This is especially critical in the
case of SGNs, given the requirement for a certain
population size of healthy SGNs that ensure the efficacy
of cochlear implants in hearing-damaged patients.
Several NFs have been identified that can promote
regeneration and enhance the function of surviving cells
(see below). Maintenance of SGNs in the damaged inner
ear may require long-term administration of these
factors; however, the osmotic pumps employed for
intracochlear infusion of NFs have a finite life-span
(Gillespie et al., 2003; Shepherd et al., 2008). Repeated
replacement of these pumps conveys the serious risk of
infection within the cochlea, which makes these devices
unsuitable for clinical applications. On the other hand,
use of viral vectors to deliver therapeutic molecules may
yield high and sustained expression of the gene of
interest (Liu et al., 2005; Konishi et al., 2008), but
carries the risk of potential toxicity. Ex vivo gene
manipulation of appropriate cell types and their
subsequent use as a source of NFs following their
transplantation into the inner ear has emerged as an
alternative therapeutic option. Various cell types have
already been tested, such as HSCs, NSCs, fibroblasts
and Schwann cells; the latter are especially interesting,
since they are amenable to genetic manipulation, can be
easily obtained and used autologously. Importantly, and
differently from the setting when differentiation of
exogenous cells into specific inner ear cell types is
sought-after, the implantation of donor cells that act as
delivery vectors for the production of trophic factors
should not require precise morphological integration of
these cells into the host tissue (Sekiya et al., 2006).
Additional support for the use of cell/gene therapy
versus the direct infusion of relevant trophic factors is
underlined by studies such as that carried out by
Pettingill and colleagues (2008), who demonstrated that
Schwann cells genetically modified to over-express
BDNF elicited a greater effect on the survival of rat
SGNs in vitro, compared to the direct application of
recombinant BDNF. These results indicate that Schwann
cells produce some additional factor(s) that acted
synergistically with the secreted BDNF. 
Okano and colleagues (2006) demonstrated for the
first time the possibility of using genetically modified
cells as vectors for the local and sustained delivery of
therapeutic agents into the cochlea. Prior to
transplantation, this group transfected the fibroblast cell
line NIH3T3 with the BDNF gene, whose product had
previously been shown to efficiently protect HCs and
SGNs from various ototoxic insults. Okano and co-
workers confirmed survival and settlement of the
engineered cells in the perilymphatic space of the
cochlea and vestibule and a significant increase in
BDNF protein levels in the inner ear. Subsequent work
by Pettingill and co-workers (2008) demonstrated that
rat Schwann cells genetically modified to over-express
BDNF or NT-3 enhanced rat SGN survival in vitro
compared to both control Schwann cells or recombinant
neurotrophin proteins. 
Interestingly, it has been observed that besides
genetically modified cells, also normal, unmodified cells
such as stem cells of various types, e.g. HSCs, BM-
MSCs or NSCs may contribute to the survival and
function of remaining inner ear cell types (Krabbe et al.,
2005; Yoshida et al., 2007; Whitlon et al., 2009). In this
regard, the beneficial effects observed following
transplantation of MSCs into injured tissue may be at
least partially mediated by their production of trophic
and protective factors (Krabbe et al., 2005; Caddick et
al., 2006). In line with this argument are also the data by
Yoshida and colleagues (2007), who reported that
treatment with HSCs ameliorated progressive HC
damage caused by transient cochlear ischemia in gerbils
and prevented a shift in ABR thresholds. While no
transdifferentiation of the implanted cells into cochlear
cells or fusion events were observed, HSC injection
appeared to up-regulate the expression of GDNF in the
OC following ischemia.
Hakuba and co-workers (2005) observed that
injection of NSCs into the inner ear of gerbils that had
suffered cochlear ischemia resulted in a markedly
reduced injury-induced ABR threshold shift and
decreased inner HC damage, compared to the non-
transplanted side. These effects were also considered to
be the result of increased production of NFs or cytokines
by the implanted cells. In an in vitro study, Chen and
colleagues (2010) showed increased proliferation of
auditory cell cultures grown in NSC-conditioned
medium, compared to controls, and correlated this effect
with higher concentrations of leukaemia inhibitory factor
(LIF) in the NSC-conditioned medium, leading to
activation of the LIF/JAK/STAT signalling pathway. LIF
had already been previously shown to improve survival
of SGNs (Marzella et al., 1999; Whitlon et al., 2006).
Regarding the use of NSCs for repair of inner ear
damage, it is also worth taking into account the
observations made by Ourednik and colleagues (2002) in
the CNS. They observed that transplanted NSCs
appeared to have an inherent ability to migrate to
damaged areas and, rather than differentiating into
“replacement” cells, rescue the damaged host neurons
from undergoing permanent functional impairment.
They attributed this positive effect of undifferentiated
NSCs to the secretion of important trophic and/or
neuroprotective factors, such as GDNF. On the other
hand, work carried out by Ito and co-workers (Iguchi et
al., 2003) showed that a population of NSCs injected
into mouse inner ears spontaneously differentiated into
glial cells, and started expressing GDNF and BDNF,
thereby contributing to SGN survival. 
In addition to the production of trophic factors,
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implanted cells may also exert beneficial effects on
remaining auditory cell types through other means, such
as the secretion of extracellular matrix proteins and the
expression of cell adhesion molecules on their surface.
Whitlon et al. (2006) reported improved survival of
SGNs that had been co-cultured with Schwann cells, as
compared to controls, and attributed this positive
outcome not only to the production of NFs by the glial
cells (Hansen et al., 2001) but also to the establishment
of direct cell-cell contacts. The Schwann cells appeared
to provide a favourable microenvironment for the
regeneration of auditory neurons and served as a
substrate for neuronal attachment and growth (Whitlon
et al., 2009). Similar observations have been recently
made with olfactory ensheathing cells (OECs):
conditioned medium from these cells promoted the
survival and proliferation of cultured SGNs (Liu et al.,
2010; Yu et al., 2010), in agreement with the reports on
the ability of these cells to secrete NFs such as NGF,
BDNF, NT-3 and GDNF. Nevertheless, survival of the
plated SGNs was most markedly enhanced when the
neurons were cultured in direct contact with the OECs
themselves (Liu et al., 2010). Interestingly, expression of
adhesion molecules implicated in neuronal survival (e.g.
NCAM) was detected in OECs (Liu et al., 2010). 
Protection via administration of survival factors
As mentioned above, maintenance of a certain
population of functional SGNs is necessary for CIs to
exert a beneficial effect following HC loss. SGN
development and survival is dependent on the presence
of various NFs as well as neural activity (Schimmang et
al., 2003; Alam et al., 2007; Hildebrand et al., 2008;
Shepherd et al., 2008) which are provided to a large
extent by HCs and SCs within the OC. While HC
degeneration is mostly irreversible by the time it is
detected, SGN loss is usually a slow process in humans,
offering a reasonably wide therapeutic window.
Regarding HC loss, factors such as GDNF and NT-3, as
well as anti-oxidants have been identified (Shoji et al.,
2000a,b; Hakuba et al., 2003; Liu et al., 2008) that could
exert a prophylactic effect on the survival and function
of HCs if administered prior to otic damage. Application
of these factors may be useful for some groups of
patients who require aminoglycoside treatment (e.g.
gentamicin) and are at risk of developing hearing loss
(Talaska et al., 2006; Bitner-Glindzicz et al., 2010;
Prayle and Smyth, 2010). Regarding the protection/
regeneration of SGNs, administration of NFs, electrical
stimulation and anti-oxidative treatment are the
approaches most extensively studied (Pettingill et al.,
2007; Shepherd et al., 2008). It has been demonstrated
that expression of NF receptors is maintained in SGNs
of deafened animals (Gillespie et al., 2004; Hurley et al.,
2004) and NF administration has resulted in improved
survival of auditory neurons (Meen et al., 2009). Of
note, improved SGN survival was also obtained with
some NF combinations in studies where the
administration of the treatment was delayed to a
timepoint when degenerative and apoptotic processes
were already ongoing (Yamagata et al., 2004; Miller et
al., 2007; Pettingill et al., 2007). In addition to improved
survival, some studies have reported enhanced
resprouting of auditory peripheral processes (Altschuler
et al., 1999; Wise et al., 2005). A considerable amount of
work has been done on the delivery of BDNF and/or NT-
3 into hearing-damaged animal models, using osmotic
pumps or alginate beads (Gillespie et al., 2004;
Yamagata et al., 2004; Noushi et al., 2005; Richardson et
al., 2005; Wise et al., 2005). Other factors that have been
administered are NGF, GDNF, CNTF, LIF, transforming
growth factor-ß (TGF-ß), and fibroblast growth factor
(FGF), alone or in different combinations (Marzella et
al., 1999; Shoji et al., 2000b; Shinohara et al., 2002;
Gillespie et al., 2004; Gillespie and Shepherd, 2005;
Miller et al., 2007). Some studies used viral vectors for
NF expression (Yagi et al., 2000; Kanzaki et al., 2002;
Nakaizumi et al., 2004), since it has been shown that
long-term administration of these compounds is
necessary in order to obtain a significant effect on SGN
survival (Gillespie et al., 2003; Richardson et al., 2005).
Very recent work has focused on the specific targeting of
nanoparticles to SGNs, using organotypic explant
cultures of the inner ear (Roy et al., 2010). This might be
a new therapeutic option for the selective delivery of
NFs that should reduce the risk of non-specific effects of
the administered factors on other cell types. Unregulated
NF administration might lead to errors in the re-
innervation patterns of the surviving SGNs, since it is
known that NFs not only exert an effect on neuron
survival but also on axon guidance (Tessarollo et al.,
2004).
Following the same trend as other studies on NF
administration, intracochlear infusion of GDNF or a
combination of BDNF and CNTF (Shinohara et al.,
2002) has been shown to enhance SGN survival in
damaged inner ears (Gillespie and Shepherd, 2005;
Fransson et al., 2010). Importantly, these two studies
associated increased SGN survival rates to significantly
lower ABR thresholds, compared to non-treated
damaged controls. Interestingly, while there have been
some reports on an accelerated loss of SGNs following
BDNF treatment withdrawal (Gillespie et al., 2003;
Shepherd et al., 2008), Ulfendahl and co-workers
(Maruyama et al., 2008; Fransson et al., 2010) reported
that the beneficial effects of GDNF administration on
SGN survival were maintained for at least two to four
weeks after the treatment had ceased. Although
differential effects of GDNF and BDNF and/or the
production of endogenous survival factors after a certain
period of time following otic injury could explain this
divergence, it must also be mentioned that the data on
the effects following BDNF withdrawal do not appear to
be consistent (Miller et al., 2006; Agterberg et al., 2009). 
Chronic electrical stimulation (ES) has been
demonstrated to enhance the effects of NFs on SGN
survival (Miller and Altschuler, 2004; Shepherd et al.,
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2005). Work done by Shepherd and colleagues (2005)
revealed that while chronic ES of damaged guinea pig
cochleae did not enhance SGN survival compared to
non-treated controls, co-treatment with both ES and
BDNF led to increased SGN survival and reduced ABR
thresholds when compared both to deafened controls and
also to cochleae that had only received BDNF. These
results pointed to a synergistic interaction between both
treatment regimes. Interestingly, it was shown that,
following an initial period of ES and BDNF co-
treatment, ES could on its own sustain SGN survival,
overcoming the requirement for continuous BDNF
administration (Shepherd et al., 2008). Highly relevant
for the possible application of NF therapy to humans is
the observation that combined ES/NT therapy protects
SGNs from degenerating and preserves functional
responses even when the application of the treatment is
delayed (Yamagata et al., 2004; Song et al., 2008;
Scheper et al., 2009) and significant neurodegeneration
has already taken place. 
Another therapeutic approach consisted in the
application of anti-oxidants, based on the observation
that otic damage of different etiologies leads to
formation of reactive oxygen species that ultimately
results in apoptotic or necrotic processes (Henderson et
al., 2006; Poirrier et al., 2010). In this context,
Maruyama and colleagues (2007) demonstrated that anti-
oxidant treatment increased both survival and electrical
responsiveness of SGNs in hearing-damaged animals. 
Conclusions
The majority of sensorineural hearing loss cases are
due to the degeneration of the mechanotransducing cells
in the inner ear, the hair cells. Their loss is irreversible
and any therapeutical approach based on the
implantation of exogenous cells into the cochlea will
face the formidable task of integrating these cells into
the highly organized and complex cytoarchitecture of the
Organ of Corti. Therefore, it is likely that current efforts
directed to the ex vivo differentiation of exogenous cells
into HC-like cells will find their most immediate use in
drug testing and expression profiling studies. The latter
studies will be crucial for the improvement of the current
HC differentiation protocols and, especially, the
establishment of future therapies, as they should shed
light on the factors that control HC specification and
differentiation in vitro, processes that have not yet been
well characterized. At present it appears that the best
approach towards HC replacement strategies would be
based on the differentiation of endogenous inner ear
cells towards the sensory lineage, as shown by the
promising results obtained by Izumikawa and colleagues
(2005) following Atoh1 overexpression in hearing-
damaged cochleae. Some evidence exists pointing to the
capacity of some supporting cell (SC) populations to act
as the sought-for stem-like cells in the inner ear (Savary
et al., 2007); the loss of their plasticity in the adult
organism has been linked to changes in their phenotype
and/or changes in the surrounding tissue. Induced
alterations in some of their properties, such as their
cytoskeletal arrangement or their quiescent status, via
Rho inhibitors (Meyers and Corwin, 2007; Burns et al.,
2008) and/or cyclin-dependent kinase inhibitors, could
perhaps potentiate the effects observed upon ectopic
expression of genes such as Atoh1.
Cell therapy approaches might be more easily
applied to protocols aimed at either promoting the
survival of cochlear cell types or replacing degenerated
auditory neurons, processes that will likely not require
such a highly precise integration of the donor cells into
the host tissue. A wide range of cell types have already
been evaluated for their possible use in cell-based
therapies. Most of them were not human in their origin
and therefore very extensive characterisation of possible
human cell sources will still be required prior to their use
in the clinic. In this regard, results obtained in our lab
using human MSCs suggest that compared to murine
MSCs there may exist important differences between
their in vitro responses to differentiation cues aimed at
driving them towards auditory sensory lineages. On the
other hand, current work on induced pluripotent stem
cells (Takahashi and Yamada, 2006; Takahashi et al.,
2006, 2007; Tsuji et al., 2010) is yielding promising
results in the auditory system (Nishimura et al., 2009;
Oshima et al., 2010); these cells might represent a
compromise between critical parameters such as ease of
isolation and expansion, phenotypic plasticity and
availability for autologous transplantation.
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